U.S. markets closed

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
118.67-0.98 (-0.82%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 8/9/2020
Current
6/30/20203/31/202012/31/20199/30/20196/30/2019
Market Cap (intraday) 5
21.70B22.34B15.27B15.21B12.11B15.34B
Enterprise Value 3
21.77B22.35B15.38B15.34B12.22B15.29B
Trailing P/E
175.96195.78N/AN/AN/AN/A
Forward P/E 1
89.2990.0952.0856.8249.26111.11
PEG Ratio (5 yr expected) 1
1.341.350.620.690.741.69
Price/Sales (ttm)
11.7812.388.889.437.8410.03
Price/Book (mrq)
6.706.904.894.954.095.23
Enterprise Value/Revenue 3
11.7952.0330.6333.7526.5139.42
Enterprise Value/EBITDA 6
114.83-2.34k114.57683.83284.34-1.67k

Trading Information

Stock Price History

Beta (5Y Monthly) 1.05
52-Week Change 361.26%
S&P500 52-Week Change 316.25%
52 Week High 3131.95
52 Week Low 362.88
50-Day Moving Average 3124.32
200-Day Moving Average 399.56

Share Statistics

Avg Vol (3 month) 31.49M
Avg Vol (10 day) 3966.03k
Shares Outstanding 5181.35M
Float 180.1M
% Held by Insiders 10.49%
% Held by Institutions 199.30%
Shares Short (Jul 14, 2020) 410.09M
Short Ratio (Jul 14, 2020) 46.1
Short % of Float (Jul 14, 2020) 46.39%
Short % of Shares Outstanding (Jul 14, 2020) 45.58%
Shares Short (prior month Jun 14, 2020) 49.85M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 6.62%
Operating Margin (ttm)-0.53%

Management Effectiveness

Return on Assets (ttm)-0.13%
Return on Equity (ttm)3.95%

Income Statement

Revenue (ttm)1.85B
Revenue Per Share (ttm)10.27
Quarterly Revenue Growth (yoy)10.80%
Gross Profit (ttm)629.58M
EBITDA 97.91M
Net Income Avi to Common (ttm)122.26M
Diluted EPS (ttm)0.68
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.38B
Total Cash Per Share (mrq)7.61
Total Debt (mrq)1.5B
Total Debt/Equity (mrq)46.39
Current Ratio (mrq)3.26
Book Value Per Share (mrq)17.87

Cash Flow Statement

Operating Cash Flow (ttm)140.01M
Levered Free Cash Flow (ttm)-82.43M